MedTrace Logo

Efficiency of Continuous Glucose Monitoring in Critically Ill Patients

NCT00494078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-11-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether, real-time continuous glucose monitoring in critically ill patients with intensive insulin therapy would increase the percentage of time of normoglycemia, defined as glucose levels below 110 mg/dl.

Conditions

  • Critical Illness

Interventions

DEVICE

Real-time glucose monitoring system (Guardian, Medtronic)

Patients randomised to the intervention arm are treated with intensive insulin therapy guided by the real time glucose monitoring system.

DRUG

intensive insulin therapy

intensive insulin therapy according to an algorithm

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Ulrike Holzinger, MD · Medical University of Vienna, Department of Medicine III

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00494078 on ClinicalTrials.gov